Episode 40: Partnering with IDNs and ACOs, with Scott Hylla, Sunovion Pharmaceuticals
In this episode, John Marchica speaks with Scott Hylla, Director of Health Systems and Managed Markets with Sunovion Pharmaceuticals. Scott and John discuss the state of pharma-IDN partnerships, pharma attitudes toward ACOs, and the future of industry-provider relations.
Key questions include:
- How does pharma align with integrated health systems (IDNs), and what are IDNs looking for in a partnership?
- Should pharma partner with ACOs, and if so, why?
- What are the key trends in health care delivery that drive pharma toward higher-level partnerships?
In this episode
Scott Hylla is the Director of Health Systems for Sunovion Pharmaceuticals Inc. He has served in various roles spanning a 28 year career in the pharmaceutical industry, most recently in leading the Sunovion Health Systems team in the development and execution of collaborative strategies in the transformational IDN marketplace.
Scott has a BS in Biology from St. John’s University and an MBA in Healthcare Management from the Opus College of Business, University of St. Thomas. He is a member of American College of Healthcare Executives and is a corporate participant in the Health Management Academy and Advisory Board.
John Marchica is a veteran health care strategist and CEO of Darwin Research Group. Previously, he was the founder and CEO of FaxWatch, a leading business intelligence and medical education company and two-time member of the Inc. 500 list of America's fastest growing companies.
John is the author of The Accountable Organization and has advised senior management on strategy and organizational change for more than a decade. John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is a faculty associate in the W.P. Carey School of Business and the College of Health Solutions at Arizona State University, and serves as an active member of the American College of Healthcare Executives.
About Darwin Research Group
Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.